October 05, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |
Biotechnology

Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


On January 23, the Subcommittee on Intellectual Property held a hearing in which the members of the committee heard testimony about the Patent Eligibility Restoration Act (PERA) introduced by Senators Coons and Tillis. I have considered case law directed to s. 101 of 25 U.S.C. for more than a decade, and was hopeful that PERA could achieve its subtitled goal of “Restoring Clarity, Certainty, and Predictability to the U.S. Patent System”. The eight panelists had submitted comments that preceded the hearing, and the hearing was live streamed. The panelists were a blue ribbon group of patent attorneys who testified before the…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

First Quarterly Stormwater Sampling Deadline of 2025 Approaching

Environmental Science
April 5, 2025

AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists

AAPS PharmSci 360 delivers research spanning the pharmaceutical product lifecycle. Thousands of scientists and leaders,…

October 5, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Sigray, Inc. v. Carl Zeis X-Ray Microscopy, Inc.—When does “No” Projection Magnification Mean “No”? |

In Sigray, Inc, v. Carl Zeis X-Ray , appeal 2023-2211 (Fed. Cir., May 23, 2025), the panel reviewed the Board’s…

Biotechnology
June 20, 2025

Crypto Unlocked: New Patent Eligibility Guidance on Blockchain Technology  

The U.S. gave crypto one of its biggest regulatory jolts in years.  With the signing of the Guiding and Establishing…

Biotechnology
November 30, 2025

Back to District Court? PTAB Strategic Recalibration in Patent Litigation

For years, parallel proceedings at the Patent Trial and Appeal Board (PTAB) were the near-automatic response of a defendant in…

Biotechnology
February 22, 2026

A Looming En Banc Decision with Potentially Damaging Consequences – EcoFactor v. Google

Proskauer and our platform provider LexBlog each use cookies to personalize content and ads, to provide social media features and…

Biotechnology
April 5, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists
October 5, 2026
Congratulations to the 2026 ACS Fellows
October 5, 2026
Immunology Startup ai3Bio Aims to Redefine What It Means to Reset the Immune System
October 5, 2026
JCB ServiceMaster 4 V26.09 DLA 2.0 Communication Fix & Customer Experience – OBDII.SHOP OFFICIAL BLOG
October 5, 2026

Life Science Magazines

A New Blueprint: Innovations in DNA Synthesis
July 7, 2026
Inside HCP Decision-Making – The 2026 Access Landscape
July 6, 2026
Checklist for Submitting to an Institutional Review Board
July 2, 2026
Unlocking the Power of Primary Care in Cronic Disease Research
July 2, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?